You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • SAT0174 Use of a 8-week observational period for predicting remission and low disease activity at 52 weeks in ra patients treated with certolizumab pegol – a multicenter study

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0174 Use of a 8-week observational period for predicting remission and low disease activity at 52 weeks in ra patients treated with certolizumab pegol – a multicenter study
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017200
Jul 2017002
Aug 2017801
Sep 2017600
Oct 20171001
Nov 20171402
Dec 2017400
Jan 20182007
Feb 20182205
Mar 20182408
Apr 20181803
May 2018800
Jun 20181200
Jul 20181001
Aug 2018401
Sep 2018203
Oct 2018406
Nov 2018604
Dec 20181202
Jan 2019005
Feb 2019003
Mar 2019206
Apr 2019002
May 2019207
Jun 2019203
Jul 2019406
Aug 2019002
Sep 2019002
Oct 2019203
Nov 2019003
Dec 2019203
Feb 2020002
Mar 2020004
Apr 2020002
May 2020002
Jun 2020401
Jul 2020603
Aug 2020202
Sep 2020801
Oct 2020201
Nov 2020400
Dec 2020202
Jan 2021002
Feb 2021003
Mar 2021200
Apr 2021203
Jun 2021002
Jul 2021002
Sep 2021001
Oct 20212015
Nov 20212013
Dec 2021402
Jan 2022402
Feb 2022200
Mar 2022001
Apr 2022201
May 20221008
Jun 20221202
Jul 20221202
Aug 2022803
Sep 2022204
Oct 2022403
Nov 2022401
Dec 2022600
Jan 2023401
Feb 2023201
Mar 2023800
Apr 2023002
May 2023203
Jul 2023204
Aug 2023001
Sep 2023001
Oct 2023001
Nov 2023001
Dec 20231000
Jan 2024600
Feb 2024201
Mar 2024406
Total3460203